Gibson Frank C, Savelli Juan, Van Dyke Thomas E, Genco Caroline Attardo
Department of Medicine, Section of Infectious Diseases, Boston University Medical School, Boston, MA, USA.
J Periodontol. 2005 Oct;76(10):1629-36. doi: 10.1902/jop.2005.76.10.1629.
BACKGROUND: Porphyromonas gingivalis is a primary etiologic agent of generalized aggressive periodontitis (GAgP), and gingipains, a group of cysteine proteinases, are critical virulence factors expressed by this organism. GAgP patients develop specific antibodies to gingipains; however, the function of these antibodies in the clearance of P. gingivalis infection is poorly understood. METHODS: In this study, we defined the levels of gingipain-specific antibodies in GAgP patient sera and examined the ability of gingipain-specific antibodies to facilitate opsonophagocytosis of P. gingivalis by human polymorphonuclear leukocytes (PMNs) using a fluorescent phagocytosis assay. RESULTS: GAgP patient sera possessed elevated levels of P. gingivalis-, arginine-gingipain (Rgp)A-, RgpB-, and lysine-gingipain (Kgp)-specific IgG (Kgp > RgpA > P. gingivalis > RgpB). Adsorption of GAgP sera with P. gingivalis whole organisms, RgpA, RgpB, and Kgp conjugated to sepharose beads reduced opsonophagocytosis of P. gingivalis by PMNs. CONCLUSIONS: Our studies demonstrate that GAgP patient sera possess elevated levels of P. gingivalis- and gingipain-specific IgG. Furthermore, we show that gingipain antibodies promote uptake of P. gingivalis by PMNs, and our data suggest that gingipain-specific antibodies may be important for the control of P. gingivalis infections.
J Periodontol. 2003-10
Mol Oral Microbiol. 2015-11-13
J Clin Periodontol. 2013-8-4
FEMS Immunol Med Microbiol. 2006-7
J Periodontol. 2003-1
J Oral Microbiol. 2024-7-9
J Clin Periodontol. 2019-1-31
PLoS One. 2017-8-3
Mol Oral Microbiol. 2015-12
BMC Microbiol. 2014-10-2
Curr Oral Health Rep. 2014-6-1